Katie Tuckwell

Trial of Tocilizumab in Giant-Cell Arteritis

John H. Stone, Katie Tuckwell, Sophie Dimonaco et al. · New England Journal of Medicine · 2017 · 1.4K citations · Full text

Life Sciences, Immunology, Pharmacotherapy +13

Comparison of lipid and lipid-associated cardiovascular risk marker changes after treatment with tocilizumab or adalimumab in patients with rheumatoid arthritis

Cem Gabay, Iain B. McInnes, Arthur Kavanaugh et al. · Annals of the Rheumatic Diseases · 2015 · 150 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Efficacy, Safety, and Pharmacodynamic Effects of the Bruton’s Tyrosine Kinase Inhibitor Fenebrutinib (GDC‐0853) in Systemic Lupus Erythematosus: Results of a Phase II, Randomized, Double‐Blind, Placebo‐Controlled Trial

David Isenberg, Richard Furie, Nicholas S. Jones et al. · Arthritis & Rheumatology · 2021 · 134 citations

Medicine, Pharmacology, Pharmacotherapy +16

Serious adverse effects associated with glucocorticoid therapy in patients with giant cell arteritis (GCA): A nested case–control analysis

Jessica C. Wilson, Khaled Sarsour, Neil Collinson et al. · Seminars in Arthritis and Rheumatism · 2016 · 131 citations

Life Sciences, Internal Medicine, Pharmacotherapy +14

Tocilizumab and remdesivir in hospitalized patients with severe COVID-19 pneumonia: a randomized clinical trial

Iván O. Rosas, George Diaz, Robert Gottlieb et al. · Intensive Care Medicine · 2021 · 124 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +14